Content about John Hammergren

March 6, 2014

McKesson on Wednesday announced that its board of directors has elected Anthony Coles as a new independent director, effective April 29, 2014.

SAN FRANCISCO — McKesson on Wednesday announced that its board of directors has elected Anthony Coles as a new independent director, effective April 29, 2014. In connection with Coles’ election, the size of the board of directors was increased from nine to 10 members, nine of whom are independent.

February 18, 2014

McKesson and Rite Aid on Tuesday announced the signing of an expanded distribution agreement to include both brand and generic pharmaceuticals.

SAN FRANCISCO — McKesson and Rite Aid on Tuesday announced the signing of an expanded distribution agreement to include both brand and generic pharmaceuticals. The new five-year agreement, which extends through March 2019, creates efficiencies for both companies by leveraging the strength of Rite Aid as one of the leading national drug store chains in the United States, and McKesson as a leader in pharmaceutical sourcing and supply chain management, the companies reported. 

January 31, 2014

Days following the acquisition of a majority stake in Celesio, McKesson Corp. reported that revenues for the third quarter ended Dec. 31 totaled $34.3 billion, up 10% compared with a year ago.

SAN FRANCISCO — Days following the acquisition of a majority stake in Celesio, McKesson Corp. on Thursday reported that revenues for the third quarter ended Dec. 31 totaled $34.3 billion, up 10% compared with a year ago.  

Third-quarter adjusted earnings per diluted share from continuing operations was $1.45 compared to $1.44 a year ago.  

January 31, 2014

If you don't succeed the first time, try, try again. That's exactly what McKesson did when it announced that it reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares. And in a separate and subsequent agreement, McKesson also picked up the Celesio convertible bonds from Elliott.

Nothing good is ever easy. "While the path to securing this acquisition was certainly not what we had originally expected, it would seem that the interested parties to this transaction continued to see the compelling strategic benefit of McKesson and Celesio uniting to form a global leader in health care services," John Hammergren, McKesson chairman, CEO and president, said of the deal. "I never lost sight of the value this transaction will bring to our customers, our supply chain partners, the employees of both organizations and our shareholders."

If you don't succeed the first time, try, try again. That's exactly what McKesson did when it announced that it reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares. And in a separate and subsequent agreement, McKesson also picked up the Celesio convertible bonds from Elliott.

January 24, 2014

McKesson announced that it has reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares for 23.50 euros per share (US $32.24 per share).

SAN FRANCISCO  — McKesson late Thursday afternoon announced that it has reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares for 23.50 euros per share (US $32.24 per share). In a separate and subsequent agreement, McKesson also announced the acquisition of Celesio convertible bonds from Elliott. These agreements are not subject to any closing conditions and the transactions are expected to close within 10 business days. 

January 14, 2014

McKesson may take another bite of the Celesio apple, suggested Sterne Agee analyst Greg Bolan in a note published Monday.

 NASHVILLE, Tenn. — McKesson may take another bite of the Celesio apple, suggested Sterne Agee analyst Greg Bolan in a note published Monday.

January 13, 2014

McKesson on Monday announced that it was unsuccessful in reaching the 75% completion condition in its offer for the outstanding shares and convertible bonds of Celesio.

SAN FRANCISCO — McKesson on Monday announced that it was unsuccessful in reaching the 75% completion condition in its offer for the outstanding shares and convertible bonds of Celesio.

October 24, 2013

McKesson on Thursday reported $33 billion in revenues for the second quarter ended Sept. 30, up 11% compared to the year-ago period.

SAN FRANCISCO — McKesson on Thursday reported $33 billion in revenues for the second quarter ended Sept. 30, up 11% compared to the year-ago period. Second-quarter adjusted earnings per diluted share was $2.27, up 19%.

October 24, 2013

McKesson on Thursday confirmed its proposed acquisition of Celesio, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, with an agreement to acquire a majority stake in Celesio for €23 per share (US$31.75 per share) and to launch parallel voluntary public tender offers for the remaining publicly traded shares and outstanding convertible bonds of Celesio.

SAN FRANCISCO — McKesson on Thursday confirmed its proposed acquisition of Celesio, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, with an agreement to acquire a majority stake in Celesio for €23 per share (US$31.75 per share) and to launch parallel voluntary public tender offers for the remaining publicly traded shares and outstanding convertible bonds of Celesio.  

October 1, 2013

McKesson on Monday announced James Beer will join the company as EVP and CFO on Oct. 9. Beer will be responsible for overseeing all financial functions for McKesson and replaces Jeff Campbell, who left the company in June 2013 to become CFO of American Express Co.

SAN FRANCISCO — McKesson on Monday announced James Beer will join the company as EVP and CFO on Oct. 9. Beer will be responsible for overseeing all financial functions for McKesson and replaces Jeff Campbell, who left the company in June 2013 to become CFO of American Express Co. Beer will also join McKesson’s executive committee. 

July 31, 2013

McKesson on Wednesday announced preliminary voting results from its annual meeting of stockholders.

SAN FRANCISCO — McKesson on Wednesday announced preliminary voting results from its annual meeting of stockholders held here earlier. All board members were re-elected and all board vote recommendations were upheld, with the exception of the advisory vote on executive compensation and the shareholder proposal on the company’s compensation clawback policy.

July 25, 2013

Distribution Solutions revenues were up 5% in the first quarter, driven mainly by strong growth in U.S. pharmaceutical direct distribution and services revenues and the acquisition of PSS World Medical. Technology Solutions revenues were up 9% in the first quarter compared to the prior year.

SAN FRANCISCO — McKesson on Thursday afternoon reported revenues of $32.2 billion, up 5%, for the first quarter ended June 30.

June 21, 2013

McKesson has announced that Jeffrey C. Campbell, EVP and CFO, will leave the company at the end of June to become the CFO of American Express.

SAN FRANCISCO — McKesson has announced that Jeffrey C. Campbell, EVP and CFO, will leave the company at the end of June to become the CFO of American Express.

Campbell has served McKesson as CFO since 2003, playing an instrumental role in extending the company’s leadership in healthcare services and information technology, the company stated.

May 8, 2013

McKesson on Tuesday reported fiscal year revenues of $122.5 billion, relatively flat as compared with the prior fiscal year.

SAN FRANCISCO — McKesson on Tuesday reported fiscal year revenues of $122.5 billion, relatively flat as compared with the prior fiscal year. Full-year adjusted earnings per diluted share was $6.33, compared to $6.38 in the prior year.

March 5, 2013

A number of pharma companies joined Monday on the launch of the CommonWell Health Alliance to better enable seamless access to healthcare data.

NEW ORLEANS — A number of pharma companies joined Monday on the launch of the CommonWell Health Alliance to better enable seamless access to healthcare data. 

February 1, 2013

McKesson Corporation on Thursday reported $31.2 billion in revenue for its third quarter ended Dec. 31, up 1%.

SAN FRANCISCO — McKesson Corporation on Thursday reported $31.2 billion in revenue for its third quarter ended Dec. 31, up 1%. 

“Our full year view of the operating performance in our Distribution Solutions segment is now better than our original expectations, and our full year view of the operating performance in the primary businesses in Technology Solution remains unchanged,” stated John Hammergren, chairman and CEO. 

October 25, 2012

McKesson and PSS World Medical on Thursday announced that the two companies have signed a definitive agreement under which McKesson will acquire all outstanding shares of PSS World Medical for $29 per share in cash in a deal valued at $2.1 billion.

SAN FRANCISCO — McKesson and PSS World Medical on Thursday announced that the two companies have signed a definitive agreement under which McKesson will acquire all outstanding shares of PSS World Medical for $29 per share in cash in a deal valued at $2.1 billion. 

August 24, 2012

McKesson on Thursday announced that Brian Tyler has been appointed EVP corporate strategy and business development, effective immediately.

SAN FRANCISCO — McKesson on Thursday announced that Brian Tyler has been appointed EVP corporate strategy and business development, effective immediately. Tyler succeeds Marc Owen, who joined McKesson Specialty Health as president earlier this year. Tyler will remain president of McKesson’s U.S. Pharmaceutical business while the company searches for his successor.

July 27, 2012

With the Supreme Court maintaining a status quo of sorts with regard to the Patient Protection and Affordable Care Act last month, retail pharmacy operators are going to need to continually drive efficiencies into their businesses, McKesson chairman and CEO John Hammergren noted during the wholesaler's first-quarter conference call.

SAN FRANCISCO — With the Supreme Court maintaining a status quo of sorts with regard to the Patient Protection and Affordable Care Act last month, retail pharmacy operators are going to need to continually drive efficiencies into their businesses, McKesson chairman and CEO John Hammergren noted during the wholesaler's first-quarter conference call.

July 29, 2011

A little less than a month following the company's IdeaShare 2011 conference held in San Francisco, McKesson reported a strong first-quarter headwind that will help support many of the initiatives announced at the show, particularly for its Health Mart independent pharmacy group.

SAN FRANCISCO — A little less than a month following the company's IdeaShare 2011 conference held here, McKesson reported a strong first-quarter headwind that will help support many of the initiatives announced at the show, particularly for its Health Mart independent pharmacy group.

October 31, 2010

In a big boost to its growing specialty pharmacy operation, drug-distribution and health services giant...